101 
Market Cap
Stock Chart
Phylogica - 30 Day Poll
Recent BLOGS About Phylogica Add New
Latest Company News
|
Phylogica Ltd (ASX:PYC) and the use of Phylomer drug prototypes
Finance News Network - Apr 8, 2010 TRANSCRIPTION OF FINANCE NEWS NETWORK INTERVIEW WITH PHYLOGICA LIMITED (ASX:PYC) CEO, DR. PAUL WATT AND EXECUTIVE CHAIRMAN, DR. DOUG WILSON Emma Pearson: Hello Emma Pearson reporting for the ...
|
|
Allowance of new European patent, major boost for Phylogica Ltd
Proactive Investors Australia - Mar 2, 2010 Perth-based biopharmaceutical company Phylogica (ASX: PYC) has achieved a major patent milestone with the allowance of new European patent further broadening the company's ownership of the ...
|
|
Cambridge-based biotech Isogenica announces new partnership with Phylogica
PRLog.Org - Feb 2, 2010 PR Log (Press Release) – Feb 02, 2010 – Isogenica Ltd today announced that it has entered into an agreement with Australian based biopharmaceutical company Phylogica to use Isogenica's CIS display ...
|
|
Phylogica Limited Announces Advanced Negotiations For Research Partnerships
Reuters Key Development - Aug 26, 2009 |
Website
Videos related to Phylogica
Company Profile
Loss for 2008-09 year: $4.49 million
Cash and cash equivalnets June 30th 2009: $3.072 million
Phylogica is a company that is engaged in the discovery and development of therapeutics directed at proteins and their interactions. The Company is engaged in the discovery of peptide-based drugs to treat inflammatory diseases.
Phylogica’s technology is based on its collection of peptides (small parts of proteins), called phylomer peptides. These phylomer peptides are drugs, which can target and disrupt the interactions of proteins that cause a variety of diseases. Phylogica uses The Blocker Trap, its yeast-to-hybrid based tool to select the phylomer/s from its collection to block the disease causing protein and create new therapies.
The company claims advanatges including:
- no antibody royalty stack
- manufacturing advantage since they can be synthesized
- compatiability with alternative delivery technologies
Relationships
- Aegis (San diego) a comapny that provide novel delivery technologies
- Affybodies (Swedish)